The Global Parp Inhibitors Market

By Author: arti ghodke
Total Articles: 227
Comment this article

The Global PARP Inhibitors Market was valued $XX Mn in 2019 and is expected to grow at a CAGR of XX% during the forecast period.
Global PARP Inhibitors Market Introduction and Overview

Cancer is the most devastating disease of our time. According to the World Health Organisation, it is the second most cause of death globally. The globally increasing prevalence of cancer has increased the demand for efficient drugs, targeted therapies, and precision medicines. Precision medicines have revolutionized cancer therapies by the concept of targeting selective cancer cells. Over the past decade Poly ADP-ribose Polymerases (PARP) have emerged as a new target in cancer therapy.

PARP inhibitors are a successful example of precision medicine, as the first drugs targeting specific cancer cells. They work by preventing cells from repairing their DNA which is damaged by the chemotherapy agents. Moreover, a combination of chemotherapy and PARP inhibitors can help in reducing the proliferation of cancer cells.
Rising cancer cases, funding initiatives by governments, and advanced treatment techniques are elevating the ...
... PARP inhibitors market. Cancer Australia’s “Supporting people with Cancer” grant initiative provides organisation with grants up to $120,000 to support projects aimed at reducing the cancer burden. Effective partnerships between organisations to improve coordination, accessibility, and development of quality cancer support networks are also responsible for the market growth.

Strict government regulations may restrain the market from growing.
Global PARP Inhibitors Market Segment Analysis

The drug type segment has dominated the Global PARP Inhibitors market. The increasing demand for drugs is boosting the market growth. Increased number of product approvals such as Lynparza (Olaprib), Niraparib, and Rucaparib by the FDA for ovarian cancer have elevated the market. Moreover, several other PARP Inhibitors that exhibit promising results are in the last stages of clinical trials.

In the Indication segment, Ovarian cancer held a dominant position in 2019. PARP Inhibitors are extensively used in ovarian cancer treatments as they help repair damaged DNA.
Global PARP Inhibitors Market Segmentation

The PARP Inhibitors Market is segmented based on-

Drug-type

• Lynparza
• Niraparib
• Rucaparib
• Talazoparib
• Veliparib

Indication

• Ovarian Cancer
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer

Distribution Channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global PARP Inhibitors Market

To know about the Research Methodology :- Request Free Sample Report
Global PARP Inhibitors Market Regional Insights

Global PARP Inhibitors Market1

North America holds a dominant position in the global PARP inhibitors market. Owing to the rising prevalence of the geriatric population and the large number of diseases and disorders, the region’s dominance is high. The rising elderly population is likely to drive the global PARP Inhibitors Market during the forecast period.
Increasing research on BRCA-mutation tumours, ovarian cancer, and awareness about the disease is generating a revenue potential for the market in the APAC region.
Scope of Global PARP Inhibitors Market: Inquire before buying

Key Players operating the Global PARP Inhibitors Market

• AstraZeneca
• Tesaro
• AbbVie Inc
• Medivation
• Clovis Oncology
• Johnson & Johnson
• GlaxoSmithKline plc
• Pfizer Inc
• Bristol-Myers Squibb
• Merck KGaA
• Genentech Inc
• Repare Therapeutics
• Sierra Oncology
• Karyopharm Therapeutics Inc
• Ono Pharmaceutical Co. Ltd

The objective of the report is to present a comprehensive analysis of the Global PARP Inhibitors Marketincluding all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global PARP Inhibitors Marketdynamics, structure by analyzing the market segments and project the Global PARP Inhibitors Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in Global PARP Inhibitors Marketmake the report investor’s guide.
For More Information Vist : https://www.maximizemarketresearch.com/market-report/global-parp-inhibitors-market/81566/

Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.